8-K: CONMED Corporation Announces Departure of Corporate Controller and Appoints Interim Replacement

CONMED Corporation's Vice President, Corporate Controller, Eric B. Staves, will depart on September 27, 2024, with Kimberly A. Lockwood named as Interim Corporate Controller effective September 30, 2024.

Summary

• Eric B. Staves, Vice President, Corporate Controller of CONMED Corporation, has announced his resignation effective September 27, 2024.
• He is leaving to pursue an executive opportunity.
• Kimberly A. Lockwood, currently Director of Financial Reporting & Controls, will serve as Interim Corporate Controller starting September 30, 2024.
• Todd W. Garner, Executive Vice President of Finance and Chief Financial Officer, will also take on the role of Principal Accounting Officer.
• Terence M. Berge, the retired Vice President, Corporate Controller, will continue as a Special Advisor to support the company and Ms. Lockwood.

Sentiment

Score: 6

Explanation: The announcement is neutral, detailing a management change. The company appears to have a plan in place for the transition, which is positive, but the departure of a key executive is a slight negative.

Positives

• The company has a clear succession plan in place with the appointment of an Interim Corporate Controller.
• The company has retained the expertise of the previous Corporate Controller, Terence M. Berge, as a Special Advisor to ensure a smooth transition.
• Kimberly A. Lockwood has been with the company since 2005 and has a strong background in financial reporting and controls.

Negatives

• The departure of the Vice President, Corporate Controller, Eric B. Staves, may cause some disruption in the short term.

Risks

• The transition to a new Corporate Controller, even on an interim basis, could pose some operational risks.
• There is a risk of potential knowledge gaps during the transition period.

Management Comments

• Todd W. Garner, Executive Vice President-Chief Financial Officer, signed the report on behalf of the company.

Industry Context

Management changes are common in the corporate world, and this announcement is a routine disclosure of such a change. The appointment of an internal candidate as interim controller suggests a focus on continuity.

Comparison to Industry Standards

• The appointment of an interim controller is a common practice in the industry to ensure continuity during management transitions.
• Many companies in the medical device sector, such as Stryker and Medtronic, have similar procedures for handling executive departures and interim appointments.
• The use of a special advisor during the transition is also a standard practice to provide support and guidance.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the departure of a key executive, but the appointment of an interim replacement should provide some reassurance.
• Employees may experience some uncertainty during the transition period.
• Customers and suppliers are unlikely to be directly impacted by this change.

Key Dates

Keywords

Corporate Controller, Interim Controller, Financial Reporting, Accounting, Management Change, CONMED Corporation